<DOC>
	<DOC>NCT00876408</DOC>
	<brief_summary>This will be a retrospective review of 30 patients with unknown primary cancer who have had commercially available RT-PCR assays performed on biopsied tumors, in order to determine if the assay results are consistent with clinical features and useful for planning initial therapy or changing therapy.</brief_summary>
	<brief_title>Review of Molecular Profiling-Real Time Polymerase Chain Reaction (Rt-Pcr) in Unknown Primary Cancer</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms, Unknown Primary</mesh_term>
	<criteria>Patients with RTPCR testing completed since commercialization of the RTPCR assay in 2007.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>RT-PCR molecular profiling assay</keyword>
	<keyword>Molecular Profiling-Real Time Polymerase Chain Reaction</keyword>
	<keyword>Unknown Primary</keyword>
	<keyword>UPC</keyword>
	<keyword>CUP</keyword>
</DOC>